Industries

Risk assessment solutions & decision analytics for life science & healthcare constituents

Industries

Within Pharma, we are working with the Clinical groups to help evaluate the risks (and opportunities) in their clinical trials before going into trial design; we are working with groups dealing with strategic portfolio analysis to help prioritize the pipeline as well as evaluate in- and out-licensing opportunities as to risk; we are also involved in drug repositioning activities to evaluate risk and new opportunities

#########
With CROs we help differentiate their service offerings to their pharma/biotech clients in early evaluation of risk and opportunities in their intended trials and/or product placement/marketing

#########
With healthcare systems and organizations, we evaluate current risk assessment, diagnostic and treatment practices helping to provide more effective and efficient care and outcomes to the benefit of their physicians and patients and at lower costs

#########
With investment groups we are involved in evaluating products and/or companies in due diligence, both for in- and out-licensing as well as investment considerations

#########
With regulatory agencies, we have been working to compare "trial populations" with the real world population because of their concerns about post-approval risk